The rate of decline of FEV1 in patients with persistent bronchial asthma;Rychlost poklesu FEV1 u pacientů s perzistujícím bronchiálním astmatem

Alergie

Volumn 4, Issue 3, 2002, Pages 195-199

  Chlumský, Jan ^a   Pokorná, Hana ^a  

^a NONE   (Czech Republic)

Author keywords

Airway remodelling; Bronchial asthma; Smoking; The rate of decline of FEV1

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; AIRWAY; ARTICLE; ASTHMA; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; MALE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0036386166     PISSN: 12123536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Strategie diagnostiky, léčby a prevence bronchiálního astmatu v ČR, Jalna, 1996.
2. Almind M, Viskum K, Evald T et al. A seven-year follow-up study of 343 adults with bronchial asthma. Dan Med Bull 1992; 39(6): 561-5.
3. Banks DE, Rando RJ, Barkman HW Jr. Persistence of toluene diisocyanate-induced asthma despite negligible workplace exposures. Chest 1990; 97(1): 121-5.
4. 1 a PEF po inhalaci hypertonického roztoku NaCl a zastoupením eozinofilních leukocytu̇ v indukovaném sputu. Alergie 2001; 2 (3): 108-111.
5. Chlumský J, Pokorná H. Vztah klinické tiže bronchiálního astmatu a stupně zánětu dýchacich cest hodnoceného podle zastoupeni eosinofilních leukocytu̇ vindukovaném sputu. Vnitř.lék. 2001; 9[47]: 604-608.
6. Dompeling E, van Schayck CP, Molema J et al. Inhaled beclomet-hasone improves the course of asthma and COPD. Eur Respir J 1992; 5 (8): 945-52.
7. Dompeling E, van Schayck CP, van Grunsven PM et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993; 118 (10): 770-8.
8. Hargreave FE. Induced sputum for the investigation of airway inflammation: evidence for its clinical application. Can Respir J 1999; 6 (2): 169-74.
9. Lange P, Parner J, Vestbo J et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339 (17): 1194-200.
10. Lieberman P, Yates SW, Welk K. Pulmonary remodeling in asthma. J Investig Allergol Clin Immunol 2001; 11 (4): 220-34.
11. Lin FJ, Dimich-Ward H, Chan-Yeung M. Longitudinal decline in lung function in patients with occupational asthma due to western red cedar. Occup Environ Med 1996; 53 (11): 753-6.
12. Magnussen H, Hargreave FE. Noninvasive monitoring of airway inflammation. Eur Respir J 2000; 16 (1): 1-2.
13. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70 (3): 171-9.
14. Postma DS, Lebowitz MD. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults. Arch Intern Med 1995; 155 (13): 1393-9.
15. Sont JK, Han J, van Krieken JM et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996; 51 (5): 496-502.
16. Sont JK, Willems LN, Bel EH et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159 (4 Pt 1): 1043-51.
17. Ulrik CS, Backer V. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. Eur Respir J 1999; 14 (4): 892-6.
18. Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47 (1): 14-8.
19. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150 (3): 629-34.
20. Van Grunsven PM, Dompeling E, van Schayck CP et al. Treatment of mild asthma with inhaled corticosteroids: is discontinuation of therapy possible? Fam Med 1996; 28 (1): 46-51.
21. Van Schayck CP, Dompeling E, Van Herwaarden CL et al. Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991; 144 (6): 1297-301.